VANGUARD ASSET MANAGEMENT, Ltd
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1680208
London, EC4N 8AF, X0
Position in BIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,238,296
+$675,716 QoQ
Shares Held
17,841
+9.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 397 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VANGUARD ASSET MANAGEMENT, Ltd holds $1,292,258,177 across 40 Medical Devices names. BIO ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,921,702 | $355,855,239 | |
| 2 | MDT |
Medtronic plc
|
2,891,131 | $226,173,178 | |
| 3 | SYK |
Stryker Corp
|
674,424 | $212,335,652 | |
| 4 | BSX |
Boston Scientific Corp
|
2,873,191 | $122,627,791 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,111,236 | $100,522,408 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
881,507 | $56,425,263 | |
| 7 | DXCM |
Dexcom Inc
|
741,928 | $49,968,850 | |
| 8 | STE |
STERIS plc
|
191,300 | $40,282,041 |
All Filings in BIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,238,296 | 17,841 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,562,580 | 16,368 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||